1488301-79-6 Usage
Description
C41H46F2N8O7, also known as Posaconazole Succinyl Ester, is a derivative of Posaconazole (P689600). It is an orally active triazole antifungal agent with potent antifungal properties. The molecular structure of this compound consists of 41 carbon atoms, 46 hydrogen atoms, 2 fluorine atoms, 8 nitrogen atoms, and 7 oxygen atoms. Its unique chemical composition allows it to effectively target and combat various fungal infections.
Uses
Used in Pharmaceutical Industry:
C41H46F2N8O7 is used as an antifungal agent for the treatment of various fungal infections. It is particularly effective against a wide range of fungal pathogens, including Candida, Aspergillus, and other yeasts and molds. The compound works by inhibiting the synthesis of fungal cell membranes, leading to the disruption of their growth and proliferation.
Used in Antifungal Treatments:
Posaconazole Succinyl Ester is used as a therapeutic agent for patients with invasive fungal infections that are resistant to conventional antifungal treatments. Its potent antifungal activity and ability to penetrate biological barriers make it a valuable option for treating life-threatening fungal infections, especially in immunocompromised patients.
Used in Prophylactic Applications:
C41H46F2N8O7 is also used as a prophylactic agent to prevent the occurrence of fungal infections in high-risk patients, such as those undergoing organ transplants, chemotherapy, or with compromised immune systems. Its use in this context helps to reduce the risk of invasive fungal infections and improve patient outcomes.
Used in Research and Development:
In addition to its clinical applications, C41H46F2N8O7 is utilized in research and development for the study of fungal pathogenesis, drug resistance, and the development of new antifungal agents. Its unique properties and potent antifungal activity make it an important tool for advancing our understanding of fungal infections and the development of novel therapeutic strategies.
Check Digit Verification of cas no
The CAS Registry Mumber 1488301-79-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,8,8,3,0 and 1 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1488301-79:
(9*1)+(8*4)+(7*8)+(6*8)+(5*3)+(4*0)+(3*1)+(2*7)+(1*9)=186
186 % 10 = 6
So 1488301-79-6 is a valid CAS Registry Number.
1488301-79-6Relevant articles and documents
Tetravalent platinum complex containing posaconazole Preparation method and application thereof
-
Paragraph 0085; 0088-0089, (2021/09/21)
The invention provides a tetravalent platinum complex containing posaconazole, a preparation method and application thereof, and the structure is shown in the formula I. The tetravalent platinum complex has obvious proliferation inhibition effect on liver cancer HepG2, lung cancer A549, colon cancer HCT116, breast cancer MDA-MB - 231 and cis-platinum drug-resistant lung adenocarcinoma, and the antitumor activity of the partial compound is obviously better than that of cisplatin. In addition, the complex has a remarkable inhibitory activity on common pathogenic fungi, shows significant inhibitory activity on posaconazole drug-resistant candida albicans, and can be used as a new drug for anti-tumor and antifungal candidate drugs.
